Asia-Pacific Nuclear Medicine Market Share

Statistics for the 2023 & 2024 Asia-Pacific Nuclear Medicine market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Nuclear Medicine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Asia-Pacific Nuclear Medicine Industry

There is moderate competition among the players in the Asia-Pacific Nuclear Medicine market. However, this competition is not by competitive pricing or product differentiation. Additionally, big players in the pharmaceutical and biotechnology industries are leveraging their vast capital reserves to venture into this market, further increasing the competition. It is expected that in the coming years, a few small to mid-sized companies will penetrate the market and hold a substantial share in the Asia-Pacific region. Some of the companies in the market are Cardinal Health, Curium, Lantheus Medical Imaging, Inc., GE Healthcare, and Bracco Diagnostic Inc.

Asia-Pacific Nuclear Medicine Market Leaders

  1. Cardinal Health

  2. Curium SAS

  3. Lantheus Medical Imaging

  4. GE Healthcare

  5. Bracco Diagnostic Inc..

*Disclaimer: Major Players sorted in no particular order

Asia-Pacific Nuclear Medicine Market  Concentration

Asia-Pacific Nuclear Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)